Management of toxicities and optimal dosing of targeted drugs in advanced kidney cancer

[摘要] Toxicities of new targeted drugs may diminish their effectiveness in advanced kidney cancer if they are not recognized and addressed properly early in patient treatment. Most of the drug-related toxicities in advanced kidney cancer are managable with supportive care without a need for long interruptions, dose reductions or permanent discontinuation of the treatment.

[学科分类] 肿瘤学